What do drug monopolies cost consumers in developing countries?

Rebecca Hellerstein

This paper quantifi es the effects of drug monopolies and low per-capita income on pharmaceutical prices in developing economies using the example of the antiretroviral drugs (ARVs) used to treat HIV. -- intellectual property rights ; international price discrimination ; TRIPS agreement ; pharmaceutical industry ; markups

MoreLess

Year of publication:	2011
Authors:	Hellerstein, Rebecca
Publisher:	New York, NY : Federal Reserve Bank of New York
Subject:	Entwicklungsländer \| Developing countries \| Monopol \| Monopoly \| Arzneimittel \| Pharmaceuticals \| Konsumentenverhalten \| Consumer behaviour

freely available

Full text |

More access options

www.newyorkfed.org

Check Google Scholar

In libraries world-wide (WorldCat)

In German libraries (KVK)

I need help

Extent:	Online-Ressource (PDF-Datei: 8 S., 141 KB) graph. Darst.
Series:	Staff reports / Federal Reserve Bank of New York. - New York, NY : [Verlag nicht ermittelbar], ZDB-ID 2189304-4. - Vol. 530
Type of publication:	Book / Working Paper
Type of publication (narrower categories):	Arbeitspapier ; Working Paper ; Graue Literatur ; Non-commercial literature
Language:	English
Notes:	Systemvoraussetzungen: Acrobat Reader
Other identifiers:	hdl:10419/60909 [Handle]
Classification:	D4 - Market Structure and Pricing ; F13 - Commercial Policy; Protection; Promotion; Trade Negotiations ; L1 - Market Structure, Firm Strategy, and Market Performance ; L65 - Chemicals; Rubber; Drugs; Biotechnology ; O34 - Intellectual Property Rights: National and International Issues
Source:	ECONIS - Online Catalogue of the ZBW

Persistent link: https://www.econbiz.de/10009411350